BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children
Clinical trial NCT06347458 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06347458
- Sponsor
- Guangzhou Bio-gene Technology Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2027-04-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.